New Cannabinoid CB9 - (Still) legal, but not harmless
|
Time to read 9 min
Free delivery on orders over €59 🚚
|
Time to read 9 min
The cannabinoid market has changed massively in recent years. While non-psychoactive CBD has long been part of everyday life for many, new substances with cryptic names and usually equally unclear properties and effects are constantly appearing. One of them: CB9.
Substances like CB9 are - at least since the ban on HHC - often advertised as supposedly legal alternatives. CB9 is said to have only a mildly psychoactive effect and to be completely legally available. But: CB9 is not a classic cannabinoid like THC and CBD, but belongs to a group of novel, barely researched synthetic drugs that are often specifically developed to exploit existing legal loopholes.
CB9 is usually advertised in online shops or social media, which often make rather vague promises ranging from relaxation and pain relief to a mild high. What is missing is information on production, mechanism of action, safety or long-term consequences. Because: Most of this simply does not exist yet.
This article explains why CB9 is not as mild and safe as providers often promise, and what - completely legal! - alternatives exist.
CB9 is not a natural cannabinoid, but a barely researched, synthetic substance with unclear effects and massive risks.
The psychoactive effect of CB9 is unpredictable. Strong psychological and physical side effects are possible, and the potential for addiction is very high.
The unclear legal situation may lead to CB9 quickly disappearing from the market. Long-term legal alternatives like cannabidiol (CBD) are the better and safer choice here.
CB9 has been floating around the internet for several years now. Nevertheless, we know surprisingly little about the substance. The cannabis plant contains more than 100 cannabinoids, not all of which are fully chemically analyzed. It therefore seems plausible that CB9 is a newly discovered natural cannabinoid.
But: CB9 is almost certainly a synthetically produced cannabinoid that only resembles known THC in its chemical structure. Such substances are completely synthesized in - mostly illegal - laboratories. New substances are constantly being developed and brought to market to circumvent bans on existing substances (e.g. HHC).
CB9 has barely been pharmacologically investigated to date. Only one group of Greek scientists examined the structure of the substance in more detail using mass spectrometry. (1) There is no research on the effects (both short- and long-term), on safe dosage, or on side effects, interactions, and other risks. Everything circulating about CB9 is largely based on user reports, marketing promises from providers, or speculation.
In contrast to CBD, whose mechanisms of action on the endocannabinoid system ECS are well researched, for CB9 it is often not even clear to which receptors it binds and how strong this binding is. This makes CB9 anything but an interesting alternative to THC and the like - it is simply extremely dangerous.
CB9 is not extracted from the cannabis plant but is created through a complex chemical reaction that typically takes place in illegal laboratories. Unlike CBD or THC, which can be directly extracted from plant material, CB9 is formed by modifying known cannabinoid structures.
Some manufacturers therefore claim that CB9 is a THC derivative - but the basis is not necessarily a natural cannabinoid. The goal is to create molecules that have a similar effect to THC but differ from it in some essential respects - usually to circumvent existing legislation.
In fact, the chemical structure of CB9 is not yet fully known. Mass spectrometry identified [2-(E)-propen-1-yl]-Delta 8-THC acetate as the main component. How this substance interacts with the body's own structures is currently completely unclear.
The processes for producing CB9 require a certain level of expertise. Nevertheless, the manufacturers are not experts, and production does not meet any quality, purity, or safety standards. Neither the starting materials used nor the resulting by-products are systematically tested for toxicology. Added to this is often a very high energy and raw material consumption in the production of synthetic drugs.
Another problem is that CB9, after synthesis, is often applied to carrier materials or incorporated into food without reliable control over the active ingredient concentration. This results in products with widely varying potency.
The manufacturing process therefore entails additional dangers for consumers: The psychoactive effect can be much stronger than expected (and known from previous consumption experiences), and you cannot assess at all what impurities and adulterants are contained.
Reports on a CB9 high are in many respects comparable to the effects of other synthetic cannabinoids (e.g., the CB9 precursor HHC). The effect usually sets in very quickly. Although the promises of manufacturers and providers speak of a mildly psychoactive effect, the high is, according to many experience reports, much stronger and more unpredictable than when consuming THC. Instead of mild relaxation or slight euphoria, many consumers report abrupt perceptual distortions, inner restlessness, and the feeling of completely losing control.
The effects on the psyche, in particular, are sometimes frightening. Anxiety, paranoia, strong heart palpitations, and racing thoughts seem to be typical. Unlike natural cannabis, CB9 lacks the balancing effect of other plant substances like terpenes or CBD, which is relevant when consuming natural cannabis flowers or full-spectrum products. The high is intense, emotionally distressing, and described as cold; similar to the consumption of chemical drugs.
Physically, symptoms such as dizziness, nausea, tremors, or circulatory problems can occur. Particularly problematic: The intensity and duration of CB9's effects are hardly predictable. Even small doses can have a very strong effect, while a new batch may turn out to be significantly weaker.
However, the use of CB9 can not only trigger a potentially unpleasant high. It can also become genuinely dangerous. Synthetic cannabinoids often bind significantly more strongly to the endocannabinoid receptors (CB1 and CB2 receptors) in the body than natural THC. These receptors are, among other things, responsible for our sleep, pain, and mood.
The binding of CB9 to the receptors can lead to strong psychological reactions, including psychosis, and also makes CB9 much more addictive than THC.
Another risk arises from the production and distribution of CB9. A key characteristic is the stability of CB9; it does not crystallize. This also distinguishes it from CBD, which can precipitate into pure crystals. (This is, in turn, exploited in the production of CBD isolates.)
Manufacturers of CB9 use this property to produce, for example, CB9 vapes or food products (gummy bears) containing CB9, which generally sell quite well - perhaps also because they appear so harmless. But: Because CB9 does not form pure crystals, the likelihood of impurities, inaccurate concentrations, or undesirable by-products from synthesis increases.
While CBD has no psychoactive properties and carries no risk of addiction, synthetic cannabinoids can trigger a strong psychological craving. There are reports of severe withdrawal symptoms: sleep disturbances, irritability, anxiety, and depressive moods are not uncommon.
Long-term effects on mental health cannot be ruled out either. CB9 is barely researched, and there are no reliable statements regarding possible damage to the brain, cardiovascular system, or other organs.
Many providers advertise CB9 as completely legal – unlike other synthetic cannabinoids, but also THC. However, the legal situation is anything but clear. In Germany, France, and many other European countries, synthetic cannabinoids fall under the "New Psychoactive Substances Act" or similar regulations. These laws are deliberately formulated to cover not only individual substances but entire substance groups.
Even if CB9 is not explicitly listed in the law, its production, possession, and consumption can still be prohibited if its structure or effect falls under the defined substance groups. In addition, the legal situation is constantly changing. Substances that are still in a legal gray area today could be banned tomorrow.
For consumers, this means not only that they might no longer be able to buy CB9 from one day to the next. If you have CB9 with you, you could become liable to prosecution overnight – not to mention possible drug tests in traffic or sports.
The hype around CB9 is emblematic of a larger problem. Whenever new laws come into effect and certain substances are banned, a new substance appears whose composition, effects, and risks are completely unclear.
Instead of relying on proven, well-researched, and natural botanicals, manufacturers' marketing promises lead people to experiment with potentially dangerous substances. In the past, many of these substances were eventually banned because it turned out how dangerous they really were. Until that happens with CB9, consumers bear the full risk.
Property |
CB9 |
THC |
CBD |
|---|---|---|---|
Origin |
Synthetically or semi-synthetically produced, not naturally detected in the cannabis plant |
Natural cannabinoid from cannabis |
Natural cannabinoid from hemp |
Research Status |
Very limited, hardly any independent studies |
Well-researched |
Very well-researched |
Psychoactive Effect |
Strongly psychoactive, unpredictable effect |
Strongly psychoactive, intoxicating |
Not psychoactive |
Intoxication |
Often intense, sometimes unpleasant, with anxiety and loss of control |
Classic cannabis high |
No intoxication |
Predictability of Effect |
Very low, strong batch and dosage fluctuations |
Relatively well estimable |
Very well estimable |
Health Risks |
High, due to lack of long-term data and strong receptor binding |
Medium to high, depending on dose and individual |
Low |
Addiction Potential |
Possible to elevated (psychological) |
Possible (psychological) |
No addiction potential |
Legal Status and Availability |
Grey area, can be banned at any time |
Strictly regulated or banned in many countries |
Permanently legal in many countries (if THC limits are met) |
Quality Control |
Mostly absent or inadequate |
Variable (currently very potent flowers and other products on the market) |
Very reliable with reputable manufacturers |
Suitable for everyday use & well-being |
No |
Limited (altered consciousness & social stigma) |
Very well suited |
Long-term use |
Not recommended |
Problematic |
Well suited |
The direct comparison clearly shows why CBD is preferable to CB9. CBD (cannabidiol) is a natural cannabinoid from the hemp plant that is not psychoactive and does not cause intoxication. Its effects are well-researched, and numerous studies are dedicated to its potentially positive effects on pain relief, stress, sleep, inflammation, and general well-being.
CBD interacts gently with the endocannabinoid system, as it only modulates the receptors. Psychological symptoms such as loss of control, anxiety, and panic do not occur. Many people describe the effect of CBD as balancing and stabilizing, not intoxicating or overwhelming.
Another crucial advantage of CBD is its legal clarity. In many countries, including Germany, CBD is permanently legal, provided that the THC content does not exceed the legal limit of 0.3%. At Hanfgeflüster, we have even decided to only sell products with less than 0.1% THC. This way, you can enjoy the full benefits of CBD, with long-term legal security and without an unwanted high.
Quality control also plays a major role with CBD. Reputable manufacturers have their products tested in laboratories, publish analysis certificates, and disclose the origin of their raw materials. Hanfgeflüster's hemp biomass, for example, comes entirely from Europe.
No matter what manufacturers promise: CB9 is not a legal and harmless alternative. In fact, it is a purely synthetic, barely researched substance whose effects and risks are completely unclear so far. Even its production and molecular structure are partially not fully clarified.
Anecdotal reports and initial analyses indicate that CB9 can not only act significantly stronger and more unpredictably than promised but also poses considerable psychological and physical dangers. In addition, there is an extremely uncertain legal situation that can change at any time and, in the worst case, can have criminal consequences for consumers.
Cannabidiol (CBD), on the other hand, is a purely natural substance from the cannabis plant whose effects are well-researched, its use safe, and its legal status clarified long-term. It brings all the positive properties that most people hope for from cannabinoids - relaxation, balance, and more well-being in everyday life - without intoxication, loss of control, or addiction.
Customer reviews:
Sources and Studies
(1) Dadiotis, E., Mpakaoukas, S., Mitsis, V., Melliou, E., & Magiatis, P. (2025). Identification of Three Novel Tetrahydrocannabinol Analogs in the European Market. Drug testing and analysis, 17(9), 1594–1600.